Clinical Trial Update: Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating intranasal ketamine for pediatric bipolar disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Ketamine (intranasal) (ketamine)

Snippet

Sponsor: Juvenile Bipolar Research Foundation | Conditions: Bipolar Disorder | Phase 2, Phase 3 | Status: TERMINATED